
What Metrics Matter Most for an SDR Team?
The answer is simple: leads. Not just any leads—relevant leads. Buyers who are ready now and those...
Read MoreSelect Page
Meet Gabe Lullo. Gabe Lullo is the CEO of Alleyoop, a sales development agency working with industry giants such as ZoomInfo, Salesloft, and Adobe. He has trained over 8,000 salespeople across diverse businesses and, during his tenure in Alleyoop, he has personally hired and managed more than 1,500 SDRs. With over two decades of experience in sales, marketing, and executive recruitment, his strategies have significantly driven Alleyoop’s growth.
Posted by Gabe Lullo | Mar 8, 2025 | Leadership, Sales |
The answer is simple: leads. Not just any leads—relevant leads. Buyers who are ready now and those...
Read MorePosted by Gabe Lullo | Feb 13, 2025 | Sales, Sales Operations |
Predictability. That one word sums me up. Anyone who knows me well knows that I thrive on...
Read MorePosted by Gabe Lullo | Jan 21, 2025 | Motivation / Wellbeing |
Why does the military have basic training? To be physically fit, yes. But more so to be mentally...
Read MorePosted by Gabe Lullo | Dec 31, 2024 | Technology |
You can get leads on LinkedIn through DMs. You just have to know what to do and what not to do. If...
Read MorePosted by Gabe Lullo | Dec 4, 2024 | Marketing, Outbound / Prospecting, Sales |
Ring. Ring. Your phone is ringing. It’s an unknown number. Do you roll the dice and answer? Or...
Read MoreApple, Amazon, and other tech companies reliant on global supply chains stand to lose the most from Trump's trade policies, but some software firms expect more demand for their services.
President Donald Trump says taxing imports will strengthen domestic manufacturing. Hours before announcing new tariffs, his administration cut support for centers that help US firms do just that.
The Heard and McDonald Islands are among the dozens of targets of President Donald Trump's latest round of tariffs. But they have no exports, because no one lives there.
A new platform from data training company Scale AI will let artificial intelligence developers find their models’ weak spots.
The elective medical industry is cashing in on plastic pollution fears, but the evidence of harm from microplastics is still deeply uncertain.